Non-Hodgkin Lymphoma | Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021, 8:00pm

Article

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

When Faced With Death, Live Life to the Fullest, Says a Cancer Survivor

December 21st 2021, 8:00pm

Article

“I had to choose one of two paths, to become the victim and let the disease control me or take control of the disease and fight for my life. The moment I chose to fight was the moment life opened all of its beauty,” writes a lymphoma survivor.

Cancer Is a Wilderness That Gives Us a Choice: Panic or Trust

December 17th 2021, 6:00pm

Article

A non-Hodgkin’s lymphoma survivor writes about how she chose to approach a stressful doctor’s appointment and how doing whatever helps may look different for everyone.

Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

December 12th 2021, 3:00pm

Article

Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma

November 26th 2021, 10:00pm

Article

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

Assessing Both Sides of the Argument for In-Home Cancer Infusions

November 18th 2021, 8:00pm

Article

Although the interest of at-home care including the administration of cancer infusions has grown since the start of the COVID-19 pandemic, hesitation looms over its convenience, cost and safety.

FDA Will Review New Drug to Treat Non-Hodgkin Lymphoma

November 1st 2021, 9:00pm

Article

The Food and Drug Administration will review parsaclisib for the treatment of patients with follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma.

It Takes a Village: Cancer Caregivers Need to Care for Themselves, Too

October 7th 2021, 1:30pm

Article

Caregivers of patients with cancer may face financial toxicity and stress — with little time to take care of themselves.

Age, Other Health Factors Can Play a Role in Cancer Treatment Decisions

September 23rd 2021, 9:00pm

Article

The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.

FDA Approval of Brukinsa in Rare Lymphoma Offers a New Option, Though Will Not Replace Other Therapies

September 22nd 2021, 3:00pm

Article

The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.